Loading...
Spotlight on fevipiprant and its potential in the treatment of asthma: evidence to date
Asthma is a heterogeneous disease, which may be classified into phenotypes and endotypes based on clinical characteristics and molecular mechanisms. The best described endotype of severe asthma is type 2 (T2)-high asthma, characterized by release of inflammatory cytokines by T helper 2 (T(H)2) cells...
Saved in:
| Published in: | J Asthma Allergy |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6324611/ https://ncbi.nlm.nih.gov/pubmed/30662272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S167973 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|